Document is current

Any future updates will be listed below

Clinical and morphologic features in five post-polycythemic myelofibrosis patients treated with ruxolitinib

Crossref DOI link: https://doi.org/10.1007/s00277-015-2429-5

Published Online: 2015-06-18

Published Print: 2015-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark